Gu F - Search Results

1

[Comparative study of chemosensitivity and efficacy between pirarubicin and epirubicin in breast cancer].

Zang MF, Zhang YM, Zhi YH, Zhai Z, Zhang M, Gu F, Zhi XC. Zang MF, et al. Among authors: gu f. Zhonghua Yi Xue Za Zhi. 2011 May 31;91(20):1388-92. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21756809 Clinical Trial. Chinese.

2

[Efficacy of adjuvant chemotherapy after left pneumonectomy on non-small cell lung cancer].

Wang M, Wang CL, Gong LQ, Gu F, Su YJ, You J. Wang M, et al. Among authors: gu f. Ai Zheng. 2007 Dec;26(12):1365-8. Ai Zheng. 2007. PMID: 18076803 Free article. Chinese.

3

[Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].

Liu FF, Wei J, Lang RG, Fan Y, Cui LF, Gu F, Fu L. Liu FF, et al. Among authors: gu f. Zhonghua Bing Li Xue Za Zhi. 2008 Aug;37(8):529-35. Zhonghua Bing Li Xue Za Zhi. 2008. PMID: 19094464 Chinese.

4

[Significance of interleukin-1beta expression and microvascular density in invasive micropapillary carcinoma of breast].

Cui LF, Guo XJ, Wei J, Liu FF, Gu F, Fan Y, Lang RG, Fu L. Cui LF, et al. Among authors: gu f. Zhonghua Bing Li Xue Za Zhi. 2008 Sep;37(9):599-603. Zhonghua Bing Li Xue Za Zhi. 2008. PMID: 19094583 Chinese.

5

[Association of HER2 genetic heterogeneity with clinicopathological characteristics in breast cancer].

Yang YL, Fan Y, Lang RG, Gu F, Fu L. Yang YL, et al. Among authors: gu f. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010 Oct;27(5):540-5. doi: 10.3760/cma.j.issn.1003-9406.2010.05.014. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2010. PMID: 20931533 Chinese.

6

[Robo1 expression in breast cancer and its relationship to brain metastasis].

Wang J, Wang L, Liu FF, Ma YJ, Fu L, Li WL, Gu F. Wang J, et al. Among authors: gu f. Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):447-51. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21875486 Chinese.

7

[Treatment and prognostic analysis of 1638 patients with non-small cell lung cancer].

Wang CL, Yue DS, Zhang ZF, Gong LQ, Su YJ, You J, Zhang Z, Gu F. Wang CL, et al. Among authors: gu f. Zhonghua Wai Ke Za Zhi. 2011 Jul 1;49(7):618-22. doi: 10.3760/cma.j.issn.0529-5815.2011.07.011. Zhonghua Wai Ke Za Zhi. 2011. PMID: 22041677 Chinese.

8

[Expression and significance of phosphorylated Girdin in breast cancer].

Xu Y, Fu L, Gu F, Ma YJ. Xu Y, et al. Among authors: gu f. Zhonghua Zhong Liu Za Zhi. 2012 Mar;34(3):205-9. doi: 10.3760/cma.j.issn.0253-3766.2012.03.010. Zhonghua Zhong Liu Za Zhi. 2012. PMID: 22780975 Chinese.

9

Peritumoral FOXP3⁺ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3⁺ regulatory T cell is prognostic predictor of breast cancer patients.

Liu F, Li Y, Ren M, Zhang X, Guo X, Lang R, Gu F, Fu L. Liu F, et al. Among authors: gu f. Breast Cancer Res Treat. 2012 Sep;135(2):459-67. doi: 10.1007/s10549-012-2132-3. Epub 2012 Jul 29. Breast Cancer Res Treat. 2012. PMID: 22842982

10

[Robo1 expression in non-small cell lung cancer and its brain metastasis].

Li XX, Jin L, Sun ZF, Gu F, Li WL, Ma YJ. Li XX, et al. Among authors: gu f. Zhonghua Zhong Liu Za Zhi. 2013 Mar;35(3):198-201. doi: 10.3760/cma.j.issn.0253-3766.2013.03.008. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23880000 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,005 results

Search Page

Filters